Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection

INTRODUCTION: Small intestinal bacterial overgrowth (SIBO) may coexist with Helicobacter pylori infection, which can be the cause of chronic gastrointestinal complaints. AIM: Evaluation of the therapeutic efficacy of amoxicillin and rifaximin in the treatment of these diseases. MATERIAL AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Konrad, Paulina, Chojnacki, Jan, Gąsiorowska, Anita, Rudnicki, Cezary, Kaczka, Aleksandra, Chojnacki, Cezary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173078/
https://www.ncbi.nlm.nih.gov/pubmed/30302165
http://dx.doi.org/10.5114/pg.2018.74228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173078/
https://www.ncbi.nlm.nih.gov/pubmed/30302165
http://dx.doi.org/10.5114/pg.2018.74228

Ejemplares similares